Cirrhosis of liver, NAS

CHIRHEP_NAS

Cirrhosis of liver is when scar tissue replaces healthy liver tissue

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K74.6 Cause of death: ICD-10 — K74.6 2 out of 7 registries used, show all original rules.	1751
4. Check minimum number of events None	1751
5. Include endpoints None	1751
6. Filter based on genotype QC (FinnGen only)	1751

Control definitions (FinnGen only)

Control exclude: CIRRHOSIS_BROAD

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K74
Name in latin: Cirrhosis hepatis alia sive non specificata

NAME	CHIRHEP_NAS
CONTROL_EXCLUDE	CIRRHOSIS_BROAD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K746
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K746
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cirrhosis of liver, NAS based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	15092	5951	8918
Only index persons	11422	4569	6853
Unadjusted period prevalence (%)
Whole population	0.22	0.17	0.25
Only index persons	0.22	0.17	0.26
Median age at first event (years)
Whole population	66.47	68.55	65.01
Only index persons	66.10	67.59	65.10

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1751	686	1065
Unadjusted period prevalence (%)	0.38	0.23	0.47
Median age at first event (years)	66.40	65.90	66.73

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1518: Matched controls
15189

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

+∞

323.0

1518

C03DA01

ATC

spironolactone; oral

17.8

323.0

821

942

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

5743.1

323.0

431

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

5484.4

323.0

417

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

10.5

323.0

1095

2992

R18

ICD-10 Finland

Ascites

78.5

323.0

430

C03CA01

ATC

furosemide; systemic

6.9

261.1

990

3245

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

11.3

244.1

508

644

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

28.4

210.5

292

126

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

45.4

200.8

248

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

6.8

182.4

540

1135

A06AD11

ATC

lactulose; oral

6.4

178.6

564

1286

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

935.2

173.6

167

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

72.0

161.5

184

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

+∞

160.3

151

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

4.6

157.0

740

2576

103

Kela drug reimbursment

Diabetes, insulin-treated

4.4

153.0

798

3043

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

19.6

129.5

201

117

A10AE04

ATC

insulin glargine; parenteral

6.2

129.2

392

802

A10BA02

ATC

metformin; oral

3.6

111.8

737

3172

D64.9

ICD-10 Finland

Anaemia, unspecified

5.3

108.7

382

912

Z94.4

ICD-10 Finland

Liver transplant status

172.5

107.8

112

215

Kela drug reimbursment

Diabetes, non-insulin-treated

3.6

105.8

663

2708

K92.0

ICD-10 Finland

Haematemesis

14.5

104.4

182

141

JJC00

NOMESCO Finland

Allogenic transplantation of liver

220.7

100.8

103

C07AA05

ATC

propranolol; systemic

4.1

99.4

474

1521

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

5.9

98.2

303

613

T90

ICPC

Diabetes non-insulin dependent

3.4

95.1

623

2580

A07AA11

ATC

rifaximin; oral

920.5

89.7

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

4.7

89.1

346

899

K76.9

ICD-10 Finland

Liver disease, unspecified

22.4

86.9

128

K92.1

ICD-10 Finland

Melaena

6.7

83.1

228

391

K72.9

ICD-10 Finland

Hepatic failure, unspecified

71.4

82.4

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

57.4

82.3

B18.2

ICD-10 Finland

Chronic viral hepatitis C

34.1

80.2

105

A05AA02

ATC

ursodeoxycholic acid; oral

21.8

80.1

119

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

29.2

80.1

109

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

5.6

79.4

254

528

K70.4

ICD-10 Finland

Alcoholic hepatic failure

+∞

75.6

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

14.5

73.4

127

K72.1

ICD-10 Finland

Chronic hepatic failure

259.0

73.0

K76.7

ICD-10 Finland

Hepatorenal syndrome

374.5

72.3

A10BH01

ATC

sitagliptin; oral

4.1

72.1

325

956

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

4.9

72.0

259

610

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.3

70.3

234

505

UJF32

NOMESCO Finland

Coloscopy

2.9

68.8

576

2678

127

Kela drug reimbursment

Transplant complication

14.7

67.6

116

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

10.0

66.1

137

149

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

8.3

65.5

152

201

D97

ICPC

Liver disease NOS

54.0

64.7

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

36.1

61.4

N02AX02

ATC

tramadol; systemic, rectal

2.5

61.0

812

4821

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

5.1

60.1

203

442

K70.1

ICD-10 Finland

Alcoholic hepatitis

600.5

59.1

A02BC02

ATC

pantoprazole; systemic

2.5

58.7

1113

7884

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

58.3

846

5207

C07AG02

ATC

carvedilol; oral

4.6

58.1

221

545

A10BB12

ATC

glimepiride; oral

4.2

57.8

240

644

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

6.8

57.7

153

246

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

124.8

56.2

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

13.9

56.0

L04AA06

ATC

mycophenolic acid; systemic

12.5

55.5

102

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.0

55.2

391

1590

TK800

NOMESCO Finland

Hemodialysis

8.9

54.9

121

146

K74.0

ICD-10 Finland

Hepatic fibrosis

+∞

54.5

K74.3

ICD-10 Finland

Primary biliary cirrhosis

33.3

53.4

K70.0

ICD-10 Finland

Alcoholic fatty liver

+∞

52.4

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

53.8

52.2

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

11.0

52.1

102

WW500

NOMESCO Finland

Blood transfusion

5.8

51.7

155

292

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

75.1

51.4

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

51.1

447

2059

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.4

50.1

195

489

I50.9

ICD-10 Finland

Heart failure, unspecified

3.0

49.6

343

1362

A10AE05

ATC

insulin detemir; parenteral

4.6

49.3

183

437

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

252.9

48.3

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.4

48.0

265

896

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.7

47.3

377

1630

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.2

46.3

153

322

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

45.9

358

1523

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

11.6

45.5

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

9.1

44.4

112

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

16.5

43.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

43.6

275

1017

A46

ICD-10 Finland

Erysipelas

2.7

42.9

334

1415

E66.00

ICD-10 Finland

Metabolic syndrome

4.4

42.7

167

418

JN3AD

NOMESCO Finland

Abdominal CT examination

3.6

41.6

204

624

Z51.5

ICD-10 Finland

Palliative care

4.0

41.4

178

487

160

Kela drug reimbursment

exenatide

7.9

41.0

128

JJ5AT

NOMESCO Finland

147.4

40.9

L04AD01

ATC

ciclosporin; systemic

9.3

40.1

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

10.6

39.5

A41.9

ICD-10 Finland

Sepsis, unspecified

5.3

39.4

127

259

R50.9

ICD-10 Finland

Fever, unspecified

2.8

39.3

290

1182

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.4

38.8

150

371

SPAT1262

SPAT

Handing over of treatment supplies

2.4

38.1

396

1953

K29.6

ICD-10 Finland

Other gastritis

13.2

37.8

K76.6

ICD-10 Finland

Portal hypertension

+∞

37.7

I81

ICD-10 Finland

Portal vein thrombosis

40.4

37.6

WX892

NOMESCO Finland

Monitored bed care

3.5

37.5

191

601

K83.0

ICD-10 Finland

Cholangitis

11.6

37.2

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.3

36.6

116

232

N02AA05

ATC

oxycodone; systemic

2.6

36.3

312

1383

K29.7

ICD-10 Finland

Gastritis, unspecified

5.1

36.2

119

248

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

36.0

243

933

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.6

35.0

172

525

R4110

NOMESCO Finland

Physiotherapy

2.2

34.9

476

2649

205

Kela drug reimbursment

Chronic hypertension

2.1

34.8

558

3326

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

126.3

34.8

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

26.9

34.2

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.7

33.4

119

270

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.2

33.1

132

335

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

33.1

210

770

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

11.9

33.0

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

32.9

334

1608

198

Kela drug reimbursment

Sorafenib

45.5

32.9

JN4CD

NOMESCO Finland

Very extensive body CT

4.2

32.6

129

325

J01MA02

ATC

ciprofloxacin; systemic

1.9

32.1

685

4522

UJF30

NOMESCO Finland

Ileoscopy through colon

3.0

31.8

205

760

E87.5

ICD-10 Finland

Hyperkalaemia

6.9

31.4

121

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

32.4

31.4

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

5.5

31.2

181

A10BH05

ATC

linagliptin; oral

3.8

30.6

139

396

M04AA01

ATC

allopurinol; systemic

2.4

30.6

307

1467

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.4

30.4

160

513

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

30.4

541

3316

I50.0

ICD-10 Finland

Congestive heart failure

3.0

30.4

190

688

A10BD07

ATC

metformin and sitagliptin; systemic

4.0

29.9

126

336

177

Kela drug reimbursment

Insulin glargine 300 U / ml

7.1

29.9

111

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.6

29.8

107

245

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.5

29.7

109

255

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

35.4

29.7

TJA10

NOMESCO Finland

Laparocentesis

51.1

29.4

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

6.7

29.0

116

A28

ICPC

Limited function/disability NOS

2.3

28.9

296

1425

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

20.5

28.3

XW000

NOMESCO Finland

Bone marrow biopsy

4.0

28.3

119

317

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

79.2

27.8

G93.4

ICD-10 Finland

Encephalopathy, unspecified

30.7

27.3

A10BJ02

ATC

liraglutide; parenteral

5.7

27.0

144

L04AX01

ATC

azathioprine; systemic

4.4

26.9

101

242

UJD02

NOMESCO Finland

Gastroscopy

3.7

26.9

124

358

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

26.5

541

3448

E66.01

ICD-10 Finland

Obesity due to excess calories

3.3

26.4

144

474

Z2446

NOMESCO Finland

Social worker

3.3

26.2

137

437

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

74.0

25.8

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

137.3

25.7

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

25.6

340

1830

WX002

NOMESCO Finland

Sedation and analgesia

2.1

25.6

351

1917

ZX120

NOMESCO Finland

Intravenous

2.6

25.5

205

864

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.0

25.4

106

281

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.5

25.3

220

968

C07AB07

ATC

bisoprolol; oral

1.8

25.1

802

5886

A10BX07

ATC

[U] liraglutide; parenteral

8.0

24.9

JN4BD

NOMESCO Finland

Extensive body CT

2.4

24.7

232

1062

R06.0

ICD-10 Finland

Dyspnoea

1.9

24.7

423

2514

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

43.6

24.6

WX872

NOMESCO Finland

Intensive care

3.3

24.6

132

429

A10BG03

ATC

pioglitazone; oral

4.7

24.5

188

P15

ICPC

Chronic alcohol abuse

5.1

24.4

158

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.8

24.2

108

303

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

24.1

958

7484

I86.4

ICD-10 Finland

Gastric varices

88.2

23.7

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

4.4

23.7

209

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.6

23.5

131

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

6.0

23.4

115

L01XE05

ATC

[U] sorafenib; oral

47.5

23.4

162

Kela drug reimbursment

liraglutide

8.2

23.3

N19

ICD-10 Finland

Unspecified kidney failure

4.1

23.3

237

ZXD05

NOMESCO Finland

Urgent procedure

1.8

23.1

489

3120

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

+∞

23.0

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

7.8

22.9

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

4.6

22.2

180

R60.0

ICD-10 Finland

Localized oedema

2.4

22.2

212

977

Z3231

NOMESCO Finland

Registered nurse

1.9

22.2

442

2756

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.7

22.1

167

F10.25

ICD-10 Finland

Alcohol dependence continuous use

7.1

22.0

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

22.0

442

2764

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.4

22.0

205

932

JCA20

NOMESCO Finland

Ligature of oesophageal varices

+∞

21.9

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.7

21.9

117

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

6.8

21.8

A10BX04

ATC

[U] exenatide; parenteral

8.6

21.7

K76.89

ICD-10 Finland

Other specified diseases of liver

223.0

21.6

J01FF01

ATC

clindamycin; systemic

1.8

21.5

445

2803

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

21.5

386

2318

R41.0

ICD-10 Finland

Disorientation, unspecified

4.2

21.4

206

JJA20

NOMESCO Finland

Open biopsy of liver

23.5

21.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.8

21.2

258

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

21.1

405

2486

N05CD07

ATC

temazepam; oral

2.2

20.9

239

1193

E66.9

ICD-10 Finland

Obesity, unspecified

4.5

20.9

177

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

77.9

20.7

J01MA12

ATC

levofloxacin; systemic

1.9

20.5

333

1918

Z2221

NOMESCO Finland

Medical doctor

1.8

20.5

419

2622

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.9

20.4

235

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.2

20.4

191

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

20.2

259

1360

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.3

20.2

183

Z3226

NOMESCO Finland

Physiotherapist

2.0

20.1

304

1704

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.0

20.0

119

414

L28

ICPC

Limited function/disability (L)

2.0

19.8

269

1447

H02AB06

ATC

prednisolone; systemic

1.7

19.7

714

5292

N05BA04

ATC

oxazepam; oral

1.9

19.7

364

2196

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

19.6

475

3128

K75.4

ICD-10 Finland

Autoimmune hepatitis

24.9

19.6

E66.8

ICD-10 Finland

Other obesity

3.5

19.4

288

JAH01

NOMESCO Finland

Laparoscopy

3.8

19.3

226

R53

ICD-10 Finland

Malaise and fatigue

1.9

19.3

310

1777

TKC20

NOMESCO Finland

Catheterisation of bladder

2.6

19.3

146

591

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

19.0

218

1091

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.5

18.9

267

R04.0

ICD-10 Finland

Epistaxis

2.5

18.9

151

632

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.0

18.8

114

403

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

18.8

275

1520

I85

ICD-10 Finland

Oesophageal varices

+∞

18.8

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

18.7

167

740

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

10.5

18.7

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

38.9

18.6

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

38.9

18.6

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.5

18.5

151

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.3

18.4

300

H02AB04

ATC

methylprednisolone; systemic

2.0

18.4

251

1349

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

18.2

102

340

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.9

17.9

112

404

A10BK03

ATC

empagliflozin; oral

2.5

17.8

149

636

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.7

17.7

223

A08

ICPC

Swelling

3.4

17.7

271

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.8

17.7

213

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

17.6

250

1364

AA1AD

NOMESCO Finland

CT of head and brain

1.7

17.5

403

2598

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

9.7

17.4

JN4AD

NOMESCO Finland

Body CT examination

2.4

17.3

158

708

A10BB01

ATC

glibenclamide; oral

3.0

17.3

100

343

N05CF01

ATC

zopiclone; oral

1.7

17.1

498

3433

I50

ICD-10 Finland

Heart failure

3.7

17.1

214

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

64.0

16.8

UJK02

NOMESCO Finland

ERCP

4.3

16.7

153

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

8.9

16.7

K74.2

ICD-10 Finland

Hepatic fibrosis with hepatic sclerosis

+∞

16.7

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.1

16.7

168

F10.24

ICD-10 Finland

Alcohol depence active use

6.3

16.6

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.8

16.6

110

413

R02

ICPC

Shortness of breath/dyspnoea

2.1

16.5

198

1004

N18.8

ICD-10 Finland

Other chronic renal failure

3.7

16.3

207

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

5.1

16.2

103

J01DB01

ATC

cefalexin; oral

1.7

16.1

1184

10299

N06AX11

ATC

mirtazapine; oral

1.7

16.1

450

3059

WX882

NOMESCO Finland

High dependency care

3.9

15.8

171

R60.9

ICD-10 Finland

Oedema, unspecified

3.0

15.8

333

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.0

15.8

312

S97

ICPC

Chronic ulcer skin

2.7

15.8

112

437

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

15.7

106

402

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.1

15.5

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.8

15.3

172

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.1

15.2

148

V03AE01

ATC

polystyrene sulfonate; oral

6.1

15.2

D05AX52

ATC

calcipotriol, combinations; topical

2.7

15.2

109

429

UJF92

NOMESCO Finland

Capsular endoscopy

4.3

15.1

134

K65.0

ICD-10 Finland

Acute peritonitis

6.7

15.1

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.9

15.0

329

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.6

14.9

112

453

D64.8

ICD-10 Finland

Other specified anaemias

4.9

14.9

100

D25

ICPC

Abdominal distension

5.6

14.9

M10.9

ICD-10 Finland

Gout, unspecified

2.3

14.9

142

651

SPAT1254

SPAT

Administration of medicine

1.9

14.7

238

1353

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

14.7

183

941

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

14.6

187

977

A10AB06

ATC

insulin glulisine; parenteral

6.8

14.5

A41.8

ICD-10 Finland

Other specified sepsis

4.6

14.5

112

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

10.2

14.5

N17.8

ICD-10 Finland

Other acute renal failure

5.5

14.4

RS220

NOMESCO Finland

5.9

14.3

N05AH04

ATC

quetiapine; oral

1.9

14.2

215

1196

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

14.2

444

3089

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.6

14.2

183

E000001

ATC

1.8

14.2

296

1834

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

42.9

14.1

B01AB05

ATC

enoxaparin; parenteral

1.6

14.0

456

3204

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.4

13.9

122

533

C01AA05

ATC

digoxin; systemic

2.2

13.9

154

753

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.3

13.8

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

24.0

13.8

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.0

13.8

142

A12BA01

ATC

potassium chloride; oral

2.7

13.8

353

C10AC01

ATC

colestyramine; oral

3.9

13.8

152

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

13.7

172

886

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

13.6

236

1378

ZXE00

NOMESCO Finland

One hour or less

1.5

13.4

563

4199

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

13.4

229

1329

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

13.4

466

3322

C09AA05

ATC

ramipril; oral

1.6

13.3

411

2838

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

8.6

13.3

A10BJ06

ATC

semaglutide; parenteral

3.2

13.2

216

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

9.1

13.2

E66.0

ICD-10 Finland

Obesity due to excess calories

6.2

13.2

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

13.2

112

483

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

4.7

13.1

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.4

13.1

110

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

6.0

13.0

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

16.9

13.0

D73.1

ICD-10 Finland

Hypersplenism

28.6

13.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

12.9

199

1114

B82

ICPC

Anaemia other/unspecified

3.7

12.9

156

C09AA02

ATC

enalapril; systemic

1.7

12.9

326

2136

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.3

12.8

126

586

K86.1

ICD-10 Finland

Other chronic pancreatitis

7.3

12.8

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.3

12.8

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

5.3

12.7

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

12.7

550

4120

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.7

12.6

346

K74

ICD-10 Finland

Fibrosis and cirrhosis of liver

+∞

12.5

J94.8

ICD-10 Finland

Other specified pleural conditions

4.4

12.4

102

K83.1

ICD-10 Finland

Obstruction of bile duct

5.7

12.4

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

12.4

200

1135

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

8.1

12.3

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

11.7

12.3

E87.6

ICD-10 Finland

Hypokalaemia

3.2

12.3

200

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.4

12.3

103

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

14.5

12.3

D50.8

ICD-10 Finland

Other iron deficiency anaemias

5.8

12.3

A98

ICPC

Health maint/preventive medicine

0.6

12.2

1201

13091

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.6

12.1

154

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

12.1

407

D07AC01

ATC

betamethasone; topical

1.5

12.1

483

3541

SPAT1255

SPAT

Intravenous administration of medicine

2.2

12.1

119

554

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

8.2

12.1

3A422

NOMESCO Finland

21.5

12.0

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

21.5

12.0

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.6

12.0

A10BH02

ATC

vildagliptin; oral

3.6

11.9

156

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

47.0

11.9

A10BK01

ATC

dapagliflozin; oral

2.6

11.8

354

E83.1

ICD-10 Finland

Disorders of iron metabolism

10.6

11.8

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.7

11.7

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.3

11.7

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

5.4

11.7

JAH00

NOMESCO Finland

Laparotomy

3.3

11.6

181

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

65.4

11.6

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.1

11.6

204

Z72.2

ICD-10 Finland

Drug use

23.1

11.6

WVA20

NOMESCO Finland

Medicine administration

3.8

11.5

130

B17.1

ICD-10 Finland

Acute hepatitis C

+∞

11.5

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

11.4

124

603

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

120.9

11.4

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.7

11.4

305

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.4

11.4

414

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

11.3

111

516

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

11.2

550

4201

B01AA03

ATC

warfarin; systemic

1.6

11.2

346

2376

N07BB01

ATC

disulfiram; oral

2.6

11.2

310

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.3

11.1

105

481

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

11.1

229

1409

R60.1

ICD-10 Finland

Generalized oedema

8.6

11.0

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.4

11.0

382

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

4.4

11.0

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

11.0

165

913

K65.9

ICD-10 Finland

Peritonitis, unspecified

14.0

11.0

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

14.0

11.0

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

10.9

307

2056

A07EA06

ATC

budesonide; oral, local oral

3.0

10.9

210

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

43.6

10.9

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.4

10.9

385

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.5

10.9

147

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.4

10.8

323

Kela drug reimbursment

Sorafenib

28.2

10.7

E86

ICD-10 Finland

Volume depletion

3.4

10.7

149

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

21.6

10.7

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

60.4

10.6

B80

ICPC

Iron deficiency anaemia

3.9

10.6

109

3AC01

NOMESCO Finland

5.3

10.6

UJF02

NOMESCO Finland

Peroral enteroscopy

8.0

10.6

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.8

10.6

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

14.3

10.5

K76.4

ICD-10 Finland

Peliosis hepatis

110.7

10.4

N05BA01

ATC

diazepam; systemic, rectal

1.8

10.4

194

1155

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.2

10.4

164

K02.2

ICD-10 Finland

Caries of cementum

2.6

10.4

293

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

10.4

244

1556

RS120

NOMESCO Finland

16.2

10.4

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

3.0

10.3

202

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.4

10.3

143

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

10.3

158

881

D69.5

ICD-10 Finland

Secondary thrombocytopenia

10.7

10.3

A10BD03

ATC

metformin and rosiglitazone; systemic

4.1

10.2

K80.8

ICD-10 Finland

Other cholelithiasis

4.6

10.2

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

10.2

187

1108

TK810

NOMESCO Finland

Hemofiltration

7.5

10.2

C02EA02

ATC

2.4

10.2

357

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.5

10.1

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.8

10.1

242

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.1

10.0

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.4

10.0

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

10.1

10.0

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.2

10.0

163

A40.8

ICD-10 Finland

Other streptococcal sepsis

5.8

10.0

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

5.8

10.0

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

40.3

10.0

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

40.3

10.0

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

6.8

9.9

K55.2

ICD-10 Finland

Angiodysplasia of colon

6.8

9.9

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

9.9

373

2678

F05.9

ICD-10 Finland

Delirium, unspecified

3.5

9.9

127

A02BC01

ATC

omeprazole; systemic

1.5

9.9

396

2884

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.3

9.8

154

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

3.1

9.8

171

A10BJ05

ATC

dulaglutide; parenteral

5.7

9.8

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

9.8

248

1613

N06AB04

ATC

citalopram; systemic

1.6

9.8

284

1913

N05BA12

ATC

alprazolam; oral

1.9

9.8

144

789

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.2

9.8

155

JAF10

NOMESCO Finland

Repair of umbilical hernia

3.2

9.7

161

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

6.6

9.7

A10BG02

ATC

rosiglitazone; oral

4.2

9.7

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

9.7

421

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.5

9.7

328

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

5.9

9.7

C08CA01

ATC

amlodipine; oral

1.4

9.7

545

4248

Z72.1

ICD-10 Finland

Alcohol use

4.9

9.6

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

9.6

159

909

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

5.1

9.6

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

9.1

9.5

UJK12

NOMESCO Finland

Peroral cholangioscopy

15.1

9.5

H3600, E113

ICD-10 Finland

4.1

9.5

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.2

9.5

148

130

Kela drug reimbursment

Malignant tumour

1.9

9.4

140

772

N03AX16

ATC

pregabalin; oral

1.5

9.4

327

2302

JJA44

NOMESCO Finland

Laparoscopic destruction of lesion of liver

100.6

9.4

SPAT1088

SPAT

Blood transfusion

7.6

9.4

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

9.4

111

558

M01AB01

ATC

indometacin; systemic, rectal

1.9

9.4

141

778

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

30.2

9.4

2BD01

NOMESCO Finland

17.6

9.4

I98.2

ICD-10 Finland

Oesophageal varices without bleeding in diseases classified elsewhere

+∞

9.4

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.4

9.4

ZX108

NOMESCO Finland

Inhalation

5.9

9.4

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

21.8

9.4

3A064

NOMESCO Finland

8.1

9.3

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

9.3

100

485

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.8

9.3

102

K08.3

ICD-10 Finland

Retained dental root

2.1

9.3

109

549

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

8.7

9.3

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

9.3

443

T74.1

ICD-10 Finland

Physical abuse

5.3

9.2

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.8

9.2

K07

ICPC

Swollen ankles/oedema

2.4

9.1

328

E0000UV

ATC

1.4

9.1

511

3969

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.6

9.1

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

9.1

110

1870

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.2

9.1

SPAT1265

SPAT

Breathalyser

5.6

9.1

B03XA02

ATC

darbepoetin alfa; parenteral

3.4

9.0

126

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

15.7

9.0

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

15.7

9.0

J01CF05

ATC

flucloxacillin; systemic

2.6

9.0

251

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

3.4

8.9

127

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

7.5

8.9

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

8.9

162

953

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.4

8.9

299

A10BJ01

ATC

exenatide; parenteral

5.5

8.9

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.1

8.9

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

8.8

271

1851

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.5

8.8

118

D02AE01

ATC

carbamide; topical

2.1

8.8

100

497

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

9.5

8.8

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

8.8

225

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.9

8.7

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

8.7

443

3372

A04

ICPC

Weakness/tiredness general

1.8

8.7

167

1001

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

8.7

225

1468

K65.8

ICD-10 Finland

Other peritonitis

14.1

8.7

K76.1

ICD-10 Finland

Chronic passive congestion of liver

50.3

8.7

602

Kela drug reimbursment

Children's severe malnutrition

50.3

8.7

SPAT1216

SPAT

Assessment of functional ability

1.6

8.6

226

1483

N40

ICD-10 Finland

Hyperplasia of prostate

0.6

8.6

188

2779

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

5.5

8.6

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

5.8

8.6

N06AB10

ATC

escitalopram; oral

1.6

8.6

218

1419

RS221

NOMESCO Finland

4.1

8.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

8.6

346

2512

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.8

8.6

EBA10

NOMESCO Finland

Surgical removal of tooth

1.9

8.5

123

672

J01DA01

ATC

[U] cefalexin; systemic

1.4

8.5

855

7333

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.0

8.5

155

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

4.0

8.5

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

3.8

8.4

K55.8

ICD-10 Finland

Other vascular disorders of intestine

7.4

8.4

K74.4

ICD-10 Finland

Secondary biliary cirrhosis

90.5

8.4

K75.8

ICD-10 Finland

Other specified inflammatory liver diseases

90.5

8.4

R4190

NOMESCO Finland

Nutritional therapy

2.7

8.4

209

N06AX16

ATC

venlafaxine; oral

1.7

8.4

161

967

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

6.7

8.4

A10BX02

ATC

repaglinide; oral

4.0

8.4

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

8.3

125

690

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.8

8.3

186

R10.0

ICD-10 Finland

Acute abdomen

3.0

8.3

157

C22

ICD-10 Finland

Malignant neoplasm of liver and intrahepatic bile ducts

+∞

8.3

3019

Kela drug reimbursment

Lenvatinib

+∞

8.3

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.5

8.3

266

I50.1

ICD-10 Finland

Left ventricular failure

2.2

8.3

379

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

9.5

8.3

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

8.3

501

3934

D50

ICD-10 Finland

Iron deficiency anaemia

3.9

8.3

N30.0

ICD-10 Finland

Acute cystitis

1.7

8.2

173

1068

K77

ICPC

Heart failure

3.1

8.2

136

F60.2

ICD-10 Finland

Dissocial personality disorder

14.5

8.2

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.4

8.2

299

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

8.2

144

842

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

6.5

8.2

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.2

8.2

131

E87.2

ICD-10 Finland

Acidosis

7.6

8.2

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.4

8.1

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.1

8.1

137

JKA20

NOMESCO Finland

Cholecystectomy

2.7

8.1

211

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

8.1

293

2076

R03BB04

ATC

tiotropium bromide; inhalant

1.7

8.1

158

953

L04AA01

ATC

[U] ciclosporin; systemic

4.1

8.1

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.3

8.1

303

R52.0

ICD-10 Finland

Acute pain

3.1

8.1

138

UJD10

SPAT

3.9

8.1

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

8.0

272

1897

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

10.1

8.0

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

8.0

329

F41.09

ICD-10 Finland

UNS Panic Syndrome

4.0

8.0

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

7.3

8.0

K02.9

ICD-10 Finland

Dental caries, unspecified

3.9

8.0

K51.5

ICD-10 Finland

Left sided colitis

3.1

7.9

140

TGC00

NOMESCO Finland

Bronchial lavation

2.8

7.9

184

H36.01

ICD-10 Finland

Diabetic maculopathy

4.5

7.9

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

13.1

7.9

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

7.9

194

1252

WX402

NOMESCO Finland

General anaesthesia

1.6

7.8

212

1401

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

6.1

7.8

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

7.8

102

537

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.4

7.8

Z94.0

ICD-10 Finland

Kidney transplant status

4.7

7.8

R94.5

ICD-10 Finland

Abnormal results of liver function studies

4.7

7.8

EBA00

NOMESCO Finland

Extraction of tooth

1.4

7.8

419

3208

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

0.3

7.8

620

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

7.8

144

855

30041

ICD-8 Finland

Neuroses, Depressiva

4.2

7.8

T89

ICPC

Diabetes insulin dependent

2.6

7.8

219

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.0

7.8

358

Kela drug reimbursment

liraglutide

7.0

7.8

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

4.9

7.8

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

7.8

238

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.8

7.8

171

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

7.8

231

1560

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

7.7

147

881

Z71.8

ICD-10 Finland

Other specified counselling

1.5

7.7

282

1996

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

7.7

109

592

B01AB10

ATC

tinzaparin; parenteral

1.9

7.7

107

578

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

4.1

7.7

A11CC03

ATC

alfacalcidol; systemic

2.8

7.7

166

R11

ICD-10 Finland

Nausea and vomiting

1.9

7.7

105

564

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.7

7.6

191

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.6

7.6

209

D07XC01

ATC

betamethasone, combinations; topical

1.7

7.6

168

1049

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

11.9

7.6

XF612

NOMESCO Finland

Measurement of central venous pressure

11.9

7.6

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.2

7.6

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.8

7.5

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.2

7.5

334

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

7.5

509

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.4

7.5

S18

ICPC

Laceration/cut

1.4

7.5

595

4876

C07AB02

ATC

metoprolol; systemic

1.5

7.4

309

2249

N05AA02

ATC

levomepromazine; systemic

2.3

7.4

290

L01EX02

ATC

sorafenib; oral

80.5

7.4

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.2

7.4

H25.8

ICD-10 Finland

Other senile cataract

1.7

7.3

159

989

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

10.9

7.3

JJC60

NOMESCO Finland

Total excision of transplanted liver

+∞

7.3

1508

Kela drug reimbursment

Lenvatinib

+∞

7.3

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

9.4

7.3

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

9.4

7.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

7.3

141

851

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

5.2

7.2

A10BX01

ATC

guar gum; systemic

2.3

7.2

300

XX4BW

NOMESCO Finland

15.8

7.2

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

0.5

7.2

1041

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

7.2

116

660

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

7.2

119

681

M10.0

ICD-10 Finland

Idiopathic gout

2.4

7.2

242

S76

ICPC

Skin infection other

2.1

7.2

374

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.4

7.1

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

30.1

7.1

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

20.1

7.1

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

7.1

248

1737

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

7.1

389

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

5.3

7.1

WZC30

NOMESCO Finland

Teaching

1.6

7.1

186

1219

P01AB01

ATC

metronidazole; oral, rectal

1.4

7.0

484

3859

A10BB07

ATC

glipizide; oral

3.4

7.0

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.7

7.0

168

K81.0

ICD-10 Finland

Acute cholecystitis

2.9

7.0

138

N06AB06

ATC

sertraline; oral

1.8

7.0

114

649

D07AA02

ATC

hydrocortisone; topical

1.6

7.0

159

1006

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.9

6.9

140

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

6.9

293

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.3

6.9

K85

ICD-10 Finland

Acute pancreatitis

3.1

6.9

114

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

6.9

306

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

7.6

6.9

R77.0

ICD-10 Finland

Abnormality of albumin

13.8

6.9

R31

ICD-10 Finland

Unspecified haematuria

1.7

6.9

155

976

P16

ICPC

Acute alcohol abuse

3.9

6.9

C03AA03

ATC

hydrochlorothiazide; oral

1.7

6.9

150

935

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

6.8

148

921

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

11.0

6.8

SPAT1251

SPAT

Organisation of medication

2.4

6.8

237

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.9

6.8

SPAT1263

SPAT

Sampling

1.3

6.8

559

4587

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

6.7

245

1733

RJ411

NOMESCO Finland

7.2

6.7

M01AH05

ATC

etoricoxib; oral

0.8

6.7

562

6668

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

6.7

460

K81.9

ICD-10 Finland

Cholecystitis, unspecified

4.0

6.7

N05AB01

ATC

dixyrazine; systemic

3.7

6.7

RD210

NOMESCO Finland

3.2

6.7

106

S29

ICPC

Skin symptom/complaint other

1.5

6.7

222

1541

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

5.2

6.6

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

7.8

6.6

L29.9

ICD-10 Finland

Pruritus, unspecified

2.9

6.6

133

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

6.6

221

1532

WX730

NOMESCO Finland

Conventional respirator

3.1

6.6

107

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.6

6.6

A02BC05

ATC

esomeprazole; systemic

1.3

6.6

542

4442

WX722

NOMESCO Finland

PEEP

2.1

6.6

374

N06AX03

ATC

mianserin; oral

2.1

6.6

349

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.4

6.5

228

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.7

6.5

148

N03AX14

ATC

levetiracetam; systemic

2.7

6.5

158

Z71.9

ICD-10 Finland

Counselling, unspecified

2.1

6.5

341

N03AX12

ATC

gabapentin; oral

1.5

6.5

199

1355

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

6.5

492

A10AE06

ATC

insulin degludec; parenteral

2.6

6.5

173

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.6

6.5

173

A03

ICPC

Fever

1.6

6.5

165

1074

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

6.5

321

2412

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

70.1

6.4

5716A

ICD-9 Finland

Chronic liver disease and cirrhosis, Biliary cirrhosis[CIRRHOSIS BILIARIS PRIMARIA]

70.1

6.4

SPAT1229

SPAT

Assessment of need for aid

1.7

6.4

123

739

474

NOMESCO Finland

14.4

6.4

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.5

6.4

1093

C09BA02

ATC

enalapril and diuretics; systemic

1.7

6.4

129

787

C07AB03

ATC

atenolol; systemic

1.9

6.4

504

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

6.0

6.3

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

11.1

6.3

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.6

6.3

ZZA00

NOMESCO Finland

Split skin graft

2.4

6.3

219

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

4.0

6.3

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.0

6.3

K29.2

ICD-10 Finland

Alcoholic gastritis

9.3

6.3

N06AB03

ATC

fluoxetine; oral

1.6

6.3

152

976

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

18.1

6.3

A07EC02

ATC

mesalazine; oral, rectal

2.0

6.3

396

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

18.1

6.3

N06AA12

ATC

doxepin; systemic

2.0

6.3

397

JCA35

NOMESCO Finland

Endoscopic contact coagulation in oesophagus

+∞

6.3

5710A

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic fatty liver

+∞

6.3

TJA00

NOMESCO Finland

Puncture of peritoneum

26.8

6.2

D23

ICPC

Hepatomegaly

26.8

6.2

E000006

ATC

1.9

6.2

486

RJ421

NOMESCO Finland

7.1

6.2

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

6.2

131

810

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.8

6.2

539

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

6.2

205

1418

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

6.2

509

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

6.1

366

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

7.7

6.1

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.7

6.1

L84

ICD-10 Finland

Corns and callosities

2.4

6.1

205

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.0

6.1

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.6

6.1

JCA42

NOMESCO Finland

Other endoscopic procedure for hemostasis

12.6

6.1

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

8.6

6.1

H26.3

ICD-10 Finland

Drug-induced cataract

6.7

6.0

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

6.0

219

I95.2

ICD-10 Finland

Hypotension due to drugs

5.2

6.0

H3601, E113

ICD-10 Finland

2.9

6.0

115

K50.8

ICD-10 Finland

Other Crohn disease

3.6

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1228

4554

6.69

321.64

10.5

3.1

u/l

51.4

37.8

3.33

1197

4321

(3007164) IgA [Mass/volume] in Serum or Plasma

865

2426

6.07

309.44

1.8

1.5

g/l

4.6

2.5

58.78

755

1447

(3044007) Cell count panel - Peritoneal fluid

223

82.29

307.65

2.5

1.9

—

(3023183) Ammonium ion [Moles/volume] in Plasma

763

297

44.78

307.65

6.1

1.9

umol/l

46.2

34.9

2.73

698

249

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

926

2054

8.45

307.65

3.4

2.6

24.0

22.9

0.90

829

1755

(3004789) Transferrin [Mass/volume] in Serum or Plasma

930

2180

7.97

307.65

3.4

2.5

g/l

2.3

0.03

867

2031

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

715

1484

7.46

307.65

2.5

1.8

1.7

1.6

3.03

601

1271

(44816559) Phosphatidylethanol [Mass/volume] in Blood

337

210

19.64

307.65

2.0

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

863

1046

15.30

307.65

2.2

3.0

g/l

13.7

10.5

37.11

801

960

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

264

96.98

307.65

2.6

1.7

e6/l

12602.6

4073.4

0.58

151

(3034770) Mitochondria Ab [Titer] in Serum

792

303

46.92

307.65

1.3

1.2

titre

919.4

1920.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

251

112.54

307.65

1.7

1.2

g/l

10.8

16.1

1.91

181

(3028026) IgM [Mass/volume] in Serum or Plasma

815

811

17.94

307.65

1.5

1.9

g/l

1.5

1.4

0.37

749

739

(3022948) Iron [Moles/volume] in Serum or Plasma

951

2362

7.63

307.65

3.5

2.5

umol/l

12.7

12.9

0.27

904

2192

(3037522) Nuclear Ab [Titer] in Serum

841

1707

8.56

307.65

1.5

1.3

titre

480.0

545.6

0.42

216

375

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

806

1619

8.38

307.65

8.8

2.6

umol/l

16.8

8.3

11.10

753

1428

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1118

1403

20.30

307.65

5.4

1.9

g/l

0.2

70.91

1010

1311

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

681

163

67.76

307.65

3.7

2.1

u/ml

1873.6

249.1

0.61

667

158

(3017143) Hepatitis C virus Ab [Presence] in Serum

820

1225

11.71

307.65

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

865

1293

12.25

307.65

1.6

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

289

95.96

307.65

2.8

2.1

e6/l

387.6

1015.6

1.25

206

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

305

46.55

307.65

1.1

1.0

mg/l

283.0

293.0

0.50

272

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

470

165

38.58

307.65

1.2

1.1

g/l

1.6

1.5

2.70

429

153

(3033799) Differential panel - Peritoneal fluid

278

117.85

307.65

2.5

1.9

—

(40768441) Liver Pathology biopsy report

290

39.76

307.65

2.2

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

307

39.40

307.65

1.3

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

811

299

49.69

307.65

1.4

1.2

titre

89.9

77.8

0.30

(4281824)

224

110

23.21

300.29

1.4

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

316

301

12.59

297.72

1.3

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1430

6555

7.46

280.01

15.2

4.8

g/l

31.7

35.2

81.93

1399

6084

(3020779) Urea [Moles/volume] in Serum or Plasma

632

1462

6.20

275.63

13.4

7.3

mmol/l

11.7

10.2

4.10

614

1394

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

193

104

20.73

247.74

1.3

titre

178.9

129.1

0.25

(3021879) Hepatitis B virus core Ab [Presence] in Serum

431

795

6.87

234.60

1.4

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

223

183

13.82

229.32

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

130

56.09

229.22

3.9

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

163

25.21

228.32

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

221

191

13.10

219.95

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

155

25.67

218.88

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

155

25.67

218.88

1.1

1.0

—

(3042936) Bacteria identified in Isolate by Culture

714

2209

4.77

214.09

3.3

2.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1452

7806

6.05

204.94

21.7

6.2

umol/l

24.5

11.6

39.32

1432

7417

(3003458) Phosphate [Moles/volume] in Serum or Plasma

674

2065

4.68

203.12

9.1

6.0

mmol/l

1.1

1.0

5.46

635

1911

(3033658) Prothrombin time (PT) actual/Normal

951

3791

4.30

199.92

16.3

3.9

67.2

87.1

85.63

924

3706

(3012095) Magnesium [Moles/volume] in Serum or Plasma

745

2521

4.40

195.68

5.3

3.4

mmol/l

0.8

16.95

709

2369

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

341

598

6.84

193.06

3.2

3.4

u/ml

64.2

6845.2

0.84

305

508

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

295

443

7.81

193.03

2.2

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

129

27.23

186.85

4.8

2.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

924

3758

4.09

185.37

3.6

2.2

mg/l

4.0

3.0

15.70

851

3188

(3032080) INR in Blood by Coagulation assay

1270

6487

4.49

182.23

21.0

9.9

inr

1.3

0.74

349

1798

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

198

200

11.04

176.98

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1161

5665

4.12

175.43

5.0

2.7

ug/l

194.5

156.2

2.86

1112

5158

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

591

1823

4.39

172.88

3.4

4.2

u/l

242.4

249.9

0.53

572

1727

(40768797) Stomach Pathology biopsy report

630

2038

4.27

172.73

1.4

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

123

24.89

172.44

34.3

29.5

ug/l

7.3

6.9

0.74

109

(3018677) aPTT in Platelet poor plasma by Coagulation assay

694

2428

4.08

170.14

3.3

2.0

32.6

29.9

19.61

672

2355

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1020

4668

3.84

167.04

5.0

2.5

u/l

56.4

58.1

0.60

978

4307

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

209

253

9.25

163.07

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

203

242

9.36

160.24

1.4

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

197

226

9.70

160.17

1.4

1.2

u/ml

342.7

276.5

1.30

121

131

(3042733) HLA Ab [Presence] in Serum

110

27.23

159.71

1.7

5.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

537

1661

4.22

154.49

3.3

4.2

ug/l

5.0

20.4

2.25

473

1377

(3021447) Carbon dioxide [Partial pressure] in Venous blood

505

1505

4.31

152.64

6.0

3.6

kpa

5.5

5.9

9.54

492

1455

(3002032) Base excess in Venous blood by calculation

504

1504

4.30

152.01

6.1

3.6

mmol/l

0.9

2.1

6.23

392

1195

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

190

225

9.35

150.57

1.4

u/ml

124.8

128.1

0.06

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

246

396

7.06

149.79

5.6

3.5

mg/l

1.8

1.6

2.66

233

358

(3027945) Reticulocytes/100 erythrocytes in Blood

564

1856

4.01

148.04

3.2

2.5

2.3

1.8

15.04

516

1645

(3024471) HLA-A [Type]

102

26.36

146.50

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

333

735

5.36

145.86

2.1

1.8

g/l

1.0

1.6

20.03

280

642

(3024932) HLA-DR beta [Type]

101

26.08

144.52

1.0

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

211

299

7.89

144.08

8.6

5.2

iu/ml

708.1

795.3

0.06

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

332

748

5.24

141.81

5.3

3.9

mmol/l

23.0

24.2

6.54

314

676

(3048929) Epstein Barr virus Ab [Presence] in Serum

216

333

7.26

136.58

1.4

1.2

—

(3023368) Bacteria identified in Blood by Culture

929

4398

3.37

136.07

7.1

4.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

133

110

13.00

134.99

1.1

1.0

—

(3000991) Gas panel - Venous blood

452

1358

4.14

133.43

12.1

9.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

584

2117

3.64

130.72

21.5

27.7

inr

1.4

0.25

278

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

129

112

12.35

126.92

2.3

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

128

110

12.48

126.75

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

431

1364

3.87

116.82

4.4

2.4

u/l

28.5

40.9

2.76

388

1169

(3010375) cycloSPORINE [Mass/volume] in Blood

16.60

116.25

35.7

28.9

ug/l

132.3

117.2

0.80

(3044640) Blood type and Crossmatch panel - Blood

923

4672

3.06

114.85

4.7

2.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

471

1605

3.65

114.09

1.8

1.6

—

(42870588) Differential panel, method unspecified - Blood

960

4981

3.05

113.98

9.1

5.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

544

2066

3.37

110.66

10.5

7.1

mmol/l

104.4

104.3

0.14

534

2010

(3023520) Reticulocytes [#/volume] in Blood

427

1390

3.74

110.49

3.7

2.6

e9/l

83.7

69.5

7.36

331

1068

(3006315) Basophils [#/volume] in Blood

1205

7188

3.17

109.64

9.7

5.7

e9/l

0.0

2.50

1066

6157

(3001604) Monocytes [#/volume] in Blood

1200

7160

3.15

108.76

9.7

5.7

e9/l

0.6

2.10

1060

6129

(3019198) Lymphocytes [#/volume] in Blood

1216

7315

3.17

108.51

9.8

5.8

e9/l

1.6

1.9

3.29

1083

6396

(3022096) Basophils/100 leukocytes in Blood

1131

6546

3.06

107.98

10.4

6.0

0.7

0.89

1083

6083

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1384

9007

3.57

107.27

12.5

3.1

u/l

175.4

52.7

76.87

1341

8304

(3019069) Monocytes/100 leukocytes in Blood

1153

6763

3.07

107.07

10.7

6.3

9.7

8.9

11.70

1106

6296

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

16.13

106.58

1.9

1.3

—

(3006504) Eosinophils/100 leukocytes in Blood

1147

6732

3.04

105.94

10.4

6.0

3.0

2.9

0.79

1100

6244

(3002030) Lymphocytes/100 leukocytes in Blood

1161

6879

3.04

105.00

10.7

6.1

24.0

27.0

15.79

1108

6388

(3020630) Protein [Mass/volume] in Serum or Plasma

405

1315

3.71

104.72

2.0

2.8

g/l

66.2

66.3

0.07

379

1198

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

628

2679

3.10

103.93

1.4

1.2

u/ml

2.4

1.6

0.52

125

709

(3013115) Eosinophils [#/volume] in Blood

1215

7431

3.08

102.73

10.2

6.0

e9/l

0.2

5.05

1084

6483

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

200

385

5.74

100.60

3.0

2.3

220.8

201.0

1.87

195

368

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

361

1114

3.82

100.32

2.2

1.6

—

(3018010) Neutrophils/100 leukocytes in Blood

1138

6770

2.95

100.24

10.2

5.9

59.5

57.8

4.80

1091

6307

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

191

355

5.92

99.70

2.6

3.5

u/ml

218.8

1117.3

0.66

178

331

(3014111) Lactate [Moles/volume] in Serum or Plasma

410

1415

3.48

95.79

10.6

7.7

mmol/l

1.9

1.4

7.15

392

1356

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

743

3618

2.83

94.69

4.4

2.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1206

7550

2.92

93.72

14.4

7.1

mmol/l

1.2

23.79

1065

6358

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

12.03

93.69

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

148

227

7.03

93.32

2.5

3.1

u/ml

1183.1

2145.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1280

8382

2.96

89.26

13.6

9.1

e9/l

3.9

4.2

4.49

1169

7310

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

190

396

5.26

87.22

1.8

1.5

—

(3036489) Thrombin time

219

526

4.62

84.79

2.8

2.0

24.6

21.6

5.19

211

475

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1117

6924

2.70

84.79

12.3

6.3

mmol/l

1.2

27.55

1067

6247

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

23.37

84.06

1.1

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

22.13

83.58

1.1

1.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

352

1234

3.32

78.97

5.3

2.9

kpa

4.8

4.6

1.21

336

1191

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

136

230

6.33

77.85

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

126

198

6.78

77.46

1.5

1.7

g/l

1.0

0.9

0.23

104

147

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

459

1904

2.91

76.64

10.9

8.1

kpa

4.8

5.1

8.18

442

1826

(3027801) Oxygen [Partial pressure] in Arterial blood

459

1905

2.91

76.55

10.9

8.1

kpa

11.6

11.9

0.69

442

1827

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

220

575

4.23

76.09

3.6

2.8

u/ml

0.3

4.22

129

327

(3001186) Copper [Moles/volume] in Serum or Plasma

22.22

75.65

1.4

1.0

umol/l

16.1

15.7

0.18

(3018418) pH of Serum or Plasma

805

4446

2.50

75.00

6.9

4.1

7.4

0.45

174

855

(3019309) Folate [Moles/volume] in Red Blood Cells

608

2960

2.62

73.83

2.1

1.8

nmol/l

1259.1

1174.2

1.14

494

2242

(3026782) Osmolality of Urine

610

3021

2.56

70.98

3.7

2.8

mosm/kgh2o

517.7

561.4

5.51

548

2586

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

185

448

4.50

70.53

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

531

2481

2.64

69.48

3.5

3.0

e6/l

2.3

1.8

0.88

320

1386

(3003396) Base excess in Arterial blood by calculation

444

1903

2.79

68.87

11.1

8.1

mmol/l

-0.2

1.1

6.59

358

1487

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

268

860

3.50

68.67

13.1

10.7

mmol/l

23.5

24.4

4.09

251

809

(3016502) Oxygen saturation in Arterial blood

417

1740

2.83

67.99

11.5

8.4

95.5

0.03

407

1678

(3013826) Glucose [Moles/volume] in Serum or Plasma

1276

8920

2.59

67.92

12.5

5.1

mmol/l

7.9

6.8

28.79

1242

8422

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1065

6868

2.41

67.75

7.6

4.1

—

(3002582) Erythrocytes [#/volume] in Urine

805

4640

2.36

65.79

4.5

3.4

e6/l

49.5

84.8

1.15

652

3626

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

538

2588

2.56

65.73

2.3

1.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

288

1013

3.21

63.36

4.9

3.6

mmol/l

0.7

1.9

3.50

193

755

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

141

7.15

62.72

1.2

u/l

48.4

53.5

0.37

101

(3009343) pH of Capillary blood

295

1062

3.14

62.33

5.0

3.6

7.4

0.83

132

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

297

1076

3.12

62.06

5.0

3.6

kpa

4.8

5.2

8.28

285

994

(3002173) Hemoglobin [Mass/volume] in Arterial blood

380

1595

2.77

60.59

12.4

8.8

g/l

110.4

122.0

19.15

371

1537

(3030467) Casts [#/volume] in Urine by Automated count

742

4250

2.29

60.13

4.3

3.2

e6/l

0.7

0.4

2.62

597

3250

(3020682) Albumin/Creatinine [Ratio] in Urine

834

5038

2.25

59.14

4.8

4.0

mg/mmol

16.0

8.3

3.19

613

3221

(3026493) Urate [Moles/volume] in Serum or Plasma

720

4098

2.29

58.95

4.3

2.8

umol/l

4825.6

5870.8

0.22

636

3524

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1475

11422

2.85

57.62

25.6

7.6

u/l

126.6

78.7

95.12

1449

10748

(3004588) Protein electrophoresis panel - Serum or Plasma

295

1115

2.98

56.92

1.7

2.6

—

(3018095) Leukocytes [#/volume] in Urine

855

5301

2.20

55.86

5.2

3.8

e6/l

101.3

115.3

0.24

672

3889

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

156

397

4.22

55.46

1.5

1.2

iu/ml

7.5

7.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

283

1060

2.99

55.41

13.9

9.8

0.6

0.7

0.86

283

1052

(3009508) Creatinine [Moles/volume] in Urine

810

4930

2.20

55.28

4.1

3.2

mmol/l

7.0

7.7

3.99

678

4113

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

520

2656

2.36

54.06

3.3

2.8

e6/l

1.3

1.0

1.23

309

1554

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

282

1070

2.95

53.86

13.8

9.7

1.5

1.4

2.16

282

1062

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

950

6257

2.13

51.76

2.6

2.0

pmol/l

92.9

93.7

0.17

521

3313

(3012516) Albumin [Mass/volume] in Urine

782

4790

2.14

51.45

3.8

3.3

mg/l

359.1

268.4

0.28

571

3074

(3009445) Proteinase 3 Ab [Units/volume] in Serum

201

650

3.36

50.26

1.3

1.6

u/ml

9.9

26.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

10.30

49.74

3.1

1.7

umol/l

31.1

10.1

2.65

(3000093) Morphology [Interpretation] in Blood Narrative

147

6.18

49.63

1.2

1.1

—

(36304419) Bacteria [Presence] in Urine

694

4109

2.14

49.37

4.3

3.2

—

(3026008) Bacteria identified in Urine by Culture

715

4287

2.13

49.16

4.2

3.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

172

518

3.57

48.00

1.6

titre

131.4

318.5

—

(4035726)

310

1316

2.65

47.40

1.8

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

386

1819

2.44

47.34

2.1

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

366

1696

2.46

46.50

2.2

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

355

1630

2.48

45.96

4.5

3.5

—

(3017181) Myelocytes/100 leukocytes in Blood

297

1255

2.65

45.73

5.5

4.2

0.7

0.8

0.71

124

387

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

380

1815

2.40

45.01

2.1

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

621

3646

2.09

44.05

2.0

1.6

nmol/l

18.7

20.3

2.00

573

3087

(3002179) Metamyelocytes/100 leukocytes in Blood

274

1133

2.68

43.95

5.3

4.1

0.5

0.02

281

(3003181) Sodium [Moles/volume] in Urine

112

267

4.41

43.22

1.4

1.3

mmol/l

46.3

63.5

4.83

218

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

185

622

3.21

43.22

2.2

1.9

u/l

48.9

37.8

4.91

164

541

(40758558) Short blood count panel - Blood

617

3636

2.08

43.14

10.1

6.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

233

897

2.84

42.84

14.5

11.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

61.63

41.41

1.2

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

236

931

2.77

41.37

1.6

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

276

1185

2.58

40.85

5.6

4.3

0.1

0.51

116

354

(3000850) Epithelial cells [#/volume] in Urine

563

3267

2.07

40.57

3.3

2.6

e6/l

6.9

4.9

2.08

510

2887

(3022313) Gas panel - Capillary blood

208

780

2.89

40.05

5.3

3.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

191

685

3.01

39.85

2.4

2.0

ug/l

1.8

2.0

0.09

170

610

(3015235) Bicarbonate [Moles/volume] in Capillary blood

143

433

3.51

39.43

3.5

3.1

mmol/l

22.8

24.9

4.75

127

372

(3027273) Bicarbonate [Moles/volume] in Venous blood

209

794

2.85

39.26

6.3

3.2

mmol/l

24.2

25.2

2.98

204

762

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

535

3085

2.06

38.94

2.3

1.7

mg/l

2.7

1.3

6.89

477

2400

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

7.19

38.70

1.8

1.6

u/l

11.9

6.0

0.57

(3021589) Normoblasts [#/volume] in Blood

916

6374

1.92

38.28

21.0

9.9

e9/l

0.0

0.44

776

5193

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

739

4811

1.93

37.62

4.0

3.1

ng/l

2173.5

1490.0

2.24

668

4145

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

840

5718

1.90

37.19

3.5

2.2

nmol/l

71.5

77.7

7.37

783

5068

(3003434) Protein [Mass/volume] in Pleural fluid

225

4.41

36.93

1.8

1.5

g/l

27.2

32.6

2.83

201

(40760892) CBC W Ordered Manual Differential panel - Blood

520

3020

2.03

36.75

7.3

4.6

—

(3037756) Immunofixation for Serum or Plasma

123

354

3.66

36.58

1.3

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

157

528

3.17

36.52

1.7

3.9

mg/l

58.6

79.6

0.38

126

431

(1616796) Gas panel - Central venous blood

121

346

3.68

36.33

3.9

4.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

613

3.00

36.19

1.6

2.7

g/l

7.0

7.4

1.90

119

469

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

154

515

3.18

36.16

1.7

3.8

ratio

2.3

3.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

156

528

3.15

35.89

1.7

3.9

mg/l

80.7

65.5

0.54

125

429

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

171

613

2.98

35.60

1.6

2.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

231

976

2.57

35.07

1.9

1.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

170

613

2.96

35.01

1.6

2.7

g/l

4.5

3.8

3.84

116

453

(3025159) Blasts/100 leukocytes in Blood

251

1107

2.48

34.79

5.6

4.4

0.7

0.4

0.19

299

(40760888) Immunoglobulin light chains.free panel - Serum

128

392

3.44

34.62

1.6

4.0

—

(3021901) Oxygen saturation in Capillary blood

111

313

3.72

34.00

3.1

2.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1214

9465

1.92

33.73

6.3

4.5

e6/l

585.5

1800.1

1.04

158

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

113

326

3.64

33.46

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

119

358

3.49

33.07

1.4

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

103

282

3.82

32.91

1.7

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

271

1271

2.34

32.64

2.1

nmol/l

359.8

371.1

0.23

260

1166

(3012441) Differential panel - Pleural fluid

175

4.62

32.44

1.8

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

159

576

2.94

32.42

1.6

2.7

g/l

14.2

10.3

9.81

138

495

(3020191) Ethanol [Moles/volume] in Serum or Plasma

5.87

30.79

1.4

1.3

promille

0.6

1.1

2.14

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

127

5.19

30.74

1.6

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

206

4.18

30.35

1.9

1.4

e6/l

1349.2

1686.8

0.44

150

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

223

4.00

29.64

8.1

6.7

mg/l

12.6

11.8

0.77

207

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

527

3267

1.88

29.60

1.9

1.7

pmol/l

520.9

26943430.7

2.59

451

2702

(3000494) Fungus identified in Specimen by Culture

328

1729

2.10

29.39

2.0

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

153

573

2.83

29.30

1.7

2.7

g/l

3.1

0.04

121

460

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

104

310

3.50

29.29

1.2

1.5

nmol/l

0.9

0.8

0.71

258

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

242

1131

2.32

29.21

6.3

4.0

ng/l

121.2

93.8

2.57

217

984

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

151

573

2.79

28.19

2.6

2.3

ug/l

1240.2

549.2

1.06

142

541

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

278

1404

2.17

27.72

4.4

3.0

ng/l

284.4

222.7

1.32

260

1289

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

6.61

27.34

2.6

2.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

263

3.60

26.85

3.5

3.6

1.3

1.4

0.09

207

(3022145) Colonoscopy Study observation

304

1613

2.07

26.56

1.5

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

153

4.44

26.36

1.5

1.4

u/l

206.3

343.0

1.98

148

(3028308) Erythrocytes [#/volume] in Pleural fluid

184

4.10

26.15

1.9

1.4

e6/l

21004.0

100224.3

1.35

112

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

484

3025

1.83

25.91

4.6

4.0

ng/l

557.0

455.1

0.19

404

2503

(3037467) Urinalysis macro (dipstick) panel - Urine

1219

9877

1.77

25.73

6.3

4.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

8.24

25.67

1.7

1.3

ug/l

13.3

8.6

3.07

(3036782) Glucose [Moles/volume] in Pleural fluid

165

4.25

25.62

1.7

1.4

mmol/l

7.1

6.5

0.88

155

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

249

1243

2.17

25.44

3.5

2.8

ml/min/173m2

54.1

63.7

2.20

110

495

(3012501) Base excess in Blood by calculation

105

344

3.18

25.42

5.5

5.3

mmol/l

2.1

2.7

1.33

234

(3024139) IgG subclass 3 [Mass/volume] in Serum

121

4.84

25.34

1.2

1.3

g/l

0.5

0.4

1.64

(3028192) IgG subclass 2 [Mass/volume] in Serum

121

4.84

25.34

1.2

1.3

g/l

3.0

2.7

0.55

(3027135) IgG subclass 1 [Mass/volume] in Serum

121

4.84

25.34

1.2

1.3

g/l

10.8

6.5

3.31

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

145

569

2.69

25.33

2.5

2.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

5.58

25.14

1.5

—

(3024928) Oxygen saturation in Venous blood

105

347

3.16

25.06

4.4

2.8

—

(40768806) Pleura Pathology biopsy report

177

4.08

24.97

1.8

1.5

—

(36660697) Celiac disease serology panel - Serum

206

959

2.30

24.93

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

126

467

2.83

24.55

1.6

2.6

g/l

0.0

0.02

113

430

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

159

664

2.53

24.47

6.1

3.9

mmol/l

23.4

25.0

6.08

149

619

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

5.46

24.08

1.5

—

(4062490)

123

4.67

23.91

1.1

1.3

—

(3045788) Cell count panel - Pleural fluid

165

4.12

23.91

2.0

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

136

532

2.69

23.89

1.7

2.8

g/l

0.9

1.4

0.64

118

464

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

314

3.18

23.31

1.7

1.4

—

(3010421) pH of Blood

114

413

2.88

23.16

5.7

4.9

7.4

0.71

102

339

(3008037) Lactate [Moles/volume] in Venous blood

102

349

3.04

22.94

5.3

3.2

mmol/l

2.3

1.6

3.20

102

338

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

5.81

22.47

1.1

u/l

128.2

76.4

2.24

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

5.81

22.47

1.1

u/l

45.8

23.5

1.82

(3027923) C peptide [Moles/volume] in Serum or Plasma

5.16

22.19

1.3

nmol/l

1.2

1.1

0.31

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

157

682

2.43

22.17

6.4

5.9

1.8

1.6

1.22

148

639

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

118

446

2.76

22.15

1.6

2.6

g/l

0.0

0.50

105

410

(40767503) Oxygen content in Capillary blood by calculation

343

3.00

21.78

3.3

2.6

14.5

16.3

3.28

181

(3052851) Hemolysis interference index of Serum or Plasma

119

456

2.73

21.75

5.3

3.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

154

673

2.41

21.45

6.6

6.0

0.8

0.9

0.85

147

631

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

5.00

21.39

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

5.00

21.39

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

5.00

21.39

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

6.21

21.14

1.6

5.0

mg/l

52.3

69.6

0.96

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

115

441

2.72

20.99

1.6

2.6

g/l

0.0

0.00

103

409

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

124

495

2.62

20.90

1.6

2.5

g/l

34.0

37.4

6.57

109

429

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

104

379

2.85

20.90

1.4

1.5

g/l

0.2

4.18

363

(3013707) Erythrocyte sedimentation rate by Westergren method

1272

10685

1.70

20.83

6.9

4.1

mm/h

25.6

12.7

67.57

1196

9830

(3029075) Extractable nuclear Ab panel - Serum

7.15

20.81

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

4.84

20.63

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

4.84

20.63

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

4.84

20.63

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

106

393

2.81

20.63

1.3

1.5

g/l

1.1

1.2

1.50

377

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

234

1239

2.03

20.23

5.8

4.1

mmol/l

1.2

5.60

225

1081

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

15.15

20.22

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

110

422

2.71

20.06

1.4

1.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

112

4.47

19.94

1.1

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

329

2.93

19.73

5.7

3.3

mmol/l

8.5

7.6

1.56

319

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

652

4700

1.62

19.57

2.7

2.2

u/l

250.1

242.8

0.07

624

4413

(3019060) Gas panel - Arterial blood

216

1126

2.05

19.47

6.5

5.1

—

(3037121) Protein [Mass/volume] in Urine

130

558

2.44

18.81

2.9

3.2

g/l

0.3

0.2

0.17

228

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

6.29

18.49

2.9

2.3

u/ml

63455.6

4613.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

5.23

18.19

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

5.23

18.19

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

109

438

2.59

18.13

1.4

1.5

ug/g

267.0

274.2

0.11

267

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

186

3.48

18.04

1.5

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

9.65

17.91

1.2

1.8

17.1

4.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

185

3.44

17.47

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

185

3.44

17.47

1.5

—

(4198724)

7.45

17.40

10.2

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

382

2.66

17.33

1.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

186

3.42

17.33

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

201

1070

1.99

17.01

9.8

7.3

mmol/l

23.6

24.5

2.28

191

996

(3025941) Bacteria identified in Stool by Culture

150

716

2.20

16.95

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

150

3.68

16.94

4.1

3.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

185

3.38

16.77

1.5

—

(3051651) Icteric interference index of Serum or Plasma

4.44

16.65

4.0

3.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

776

5983

1.53

16.57

5.8

3.9

ng/l

45.4

57.3

0.61

648

4455

(3009871) Measles virus Ab [Titer] in Serum

7.36

16.54

1.7

1.5

—

(3035880) pH of Pleural fluid

100

4.28

16.26

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

184

3.34

16.22

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

4.55

15.91

2.1

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

4.55

15.91

2.1

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

670

5038

1.53

15.86

4.2

3.4

mmol/l

2.3

8.45

589

4358

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

328

2.67

15.35

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

328

2.67

15.35

1.5

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

138

3.62

15.09

1.1

—

(21494434) Karyotype in Bone marrow

163

3.39

14.98

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

163

3.39

14.98

3.4

3.5

62.8

55.5

1.02

110

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

6.84

14.87

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

341

2.60

14.72

1.1

1.2

u/ml

29.2

3.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

196

3.13

14.66

3.9

2.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

228

2.97

14.65

1.1

1.3

miu/ml

211.8

193.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

350

2.56

14.46

2.8

2.2

g/l

115.3

130.5

4.95

258

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

345

2.57

14.38

1.1

1.2

u/ml

11.1

7.4

0.17

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

103

452

2.36

14.20

1.8

1.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

4.99

14.07

1.4

2.8

0.00

(3044927) Protein electrophoresis panel - Urine

174

3.17

13.51

1.1

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

859

6958

1.46

13.36

4.9

3.7

estimate

0.0

0.00

188

1299

(3003694) ABO and Rh group [Type] in Blood

510

3723

1.52

13.35

1.6

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

4.62

13.31

1.4

63.7

56.3

0.47

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

371

2.44

13.27

1.8

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

856

6940

1.46

13.18

6.7

5.0

estimate

0.0

0.00

194

1323

(3009261) Glucose [Presence] in Urine by Test strip

865

7027

1.46

13.18

5.0

3.7

estimate

0.0

0.80

168

1261

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

416

2.36

13.17

2.4

2.3

ug/min

87.6

100.5

0.17

254

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

121

588

2.14

13.06

2.1

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

168

3.16

12.96

3.9

2.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

28.59

12.96

2.8

3.2

—

(3028707) Methadone [Presence] in Urine by Screen method

110

3.70

12.78

6.7

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

281

2.63

12.75

1.8

—

(3042631) Mycobacterium sp identified in Specimen

234

2.76

12.29

2.3

2.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1026

0.28

12.26

1.6

1.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

253

2.67

12.12

1.2

u/ml

90.2

45.7

—

(21494755) Public health laboratory ask at order entry panel

926

0.25

12.10

1.5

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

26.89

12.05

1.3

1.0

—

(3019225) pH of Specimen

245

1538

1.69

11.99

7.5

4.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

126

644

2.03

11.91

2.5

1.9

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

8.06

11.89

1.1

1.2

u/l

11.5

24.8

0.85

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

413

5562

0.66

11.68

3.2

4.4

23.3

21.7

0.93

172

2780

(3008757) Leukocyte morphology finding [Identifier] in Blood

190

2.90

11.65

4.0

4.2

—

(40768804) Tissue Pathology biopsy report

710

5651

1.43

11.57

2.6

2.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

+∞

11.47

1.1

0.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

280

2.52

11.31

4.8

3.7

57.3

58.3

0.21

280

(21494890) Protein electrophoresis panel - 24 hour Urine

174

2.93

11.02

1.5

2.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

450

3325

1.48

10.72

4.1

3.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

4.08

10.69

1.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

229

2.63

10.61

1.6

1.7

—

(3020891) Body temperature

126

673

1.94

10.52

7.7

4.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

4.02

10.50

2.0

2.5

u/ml

1317.5

1396.4

0.06

(3048689) Calprotectin [Mass/mass] in Stool

229

1462

1.65

10.45

2.7

2.3

ug/g

199.4

157.2

0.78

192

1163

(1761868) Lipid panel - Serum or Plasma

347

4756

0.66

10.42

4.3

3.0

—

(3004775) Volume in Urine collected for unspecified duration

134

3.11

10.08

2.0

2.2

694.0

641.4

0.23

(3000919) Neutrophils/100 leukocytes in Pleural fluid

4.36

10.06

1.2

1.3

23.8

33.1

0.68

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.05

10.05

1.3

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

103

522

2.03

9.99

6.1

4.0

mmol/l

4.0

3.9

0.33

484

(3008295) Osmolality of Serum or Plasma

152

2.94

9.85

1.3

1.4

mosm/kgh2o

276.5

276.2

0.03

110

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

287

2.39

9.82

1.3

1.2

u/l

52.9

41.9

0.28

248

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.11

9.71

1.2

1.5

umol/l

104.9

93.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

286

4027

0.65

9.66

2.3

3.1

ug/l

0.7

0.8

0.31

201

2735

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

229

2.54

9.58

1.1

iu/ml

279.4

73.2

—

(3045716) Anion gap in Serum or Plasma

3.57

9.51

2.4

2.7

mmol/l

8.7

9.8

0.77

(3013512) EKG study

584

4609

1.40

9.51

5.6

4.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

109

3.26

9.33

1.5

1.6

u/ml

30.6

27.0

—

(3002256) Pathology report gross observation

277

1900

1.54

9.31

1.3

—

(3045142) Bone marrow Pathology biopsy report

191

2.67

9.31

1.4

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

101

524

1.98

9.19

2.4

3.4

u/ml

200.9

69.0

2.79

504

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

5.97

9.13

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

402

2.12

9.10

6.5

4.7

—

(3048879) Bone marrow aspiration report

4.44

9.09

1.2

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

137

797

1.78

8.76

2.4

2.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

181

2.64

8.63

9.1

6.1

mmol/l

8.5

7.6

0.76

148

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1315

14190

0.71

8.59

6.1

4.7

mmol/l

4.0

4.5

55.24

1224

13050

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

654

0.25

8.56

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

16.36

8.55

1.4

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

6.89

8.45

1.2

87.4

82.0

—

(3000012) Reticulocyte production index

3.50

8.38

2.7

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

178

2.63

8.38

1.6

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

180

2.60

8.20

7.6

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

345

2.13

8.14

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

275

2.26

8.01

1.6

1.5

—

(3047181) Lactate [Moles/volume] in Blood

514

1.92

8.00

8.1

7.2

mmol/l

1.9

1.4

1.43

449

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

137

2.81

7.93

1.1

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

357

2.09

7.84

2.9

3.2

nmol/l

0.8

0.78

280

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1308

14079

0.72

7.80

5.9

4.6

mmol/l

1.2

1.4

57.21

1200

12846

(40768446) Kidney Pathology biopsy report

4.20

7.74

1.5

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

6.23

7.71

1.1

—

(3011288) Drugs identified in Urine by Screen method

152

2.67

7.57

8.9

1.9

—

(3026361) Erythrocytes [#/volume] in Blood

1493

15685

0.67

7.45

65.8

22.7

e12/l

4.0

4.5

133.63

1455

15198

(3035941) MCH [Entitic mass]

1493

15683

0.67

7.41

65.6

22.6

30.8

30.4

7.95

1474

15423

(3043410) Blood group antigens tested for on Red Blood Cells

4.03

7.35

1.7

2.1

—

(3010813) Leukocytes [#/volume] in Blood

1494

15688

0.67

7.33

65.8

22.8

e9/l

6.5

6.8

1.83

1459

15206

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

248

2.26

7.25

1.6

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

6.35

7.25

1.3

1.2

78.0

71.3

—

(3024731) MCV [Entitic volume]

1494

15683

0.68

7.23

65.6

22.7

93.0

91.4

20.84

1475

15426

(3038177) Helicobacter pylori Ab [Presence] in Serum

180

2.48

7.20

1.7

1.3

—

(3007461) Platelets [#/volume] in Blood

1494

15681

0.68

7.19

65.9

22.8

e9/l

168.2

243.4

205.74

1461

15247

(3008116) Ketones [Moles/volume] in Urine by Test strip

4.74

7.17

1.3

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

1495

15687

0.68

7.14

66.4

22.9

g/l

120.7

136.0

158.17

1479

15425

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1358

14485

0.72

7.11

6.4

5.2

mmol/l

2.3

2.7

48.83

1248

13227

(3000492) Spirometry study

195

1314

1.54

7.05

1.3

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

129

2.75

7.04

1.6

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

220

2.31

6.98

1.6

1.5

—

(3016879) Cocaine [Presence] in Urine

220

2.31

6.98

7.3

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

177

2.47

6.95

1.3

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

13.83

6.89

1.5

1.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

372

2850

1.39

6.88

3.7

3.1

mmol/l

2.5

7.47

325

2498

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

432

1.92

6.87

1.7

1.6

iu/ml

0.2

15.0

0.49

(3017569) Oxygen content in Arterial blood

3.13

6.60

2.2

2.8

—

(3028433) Virus identified in Specimen by Culture

3.83

6.54

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

5.23

6.49

1.8

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

234

2.21

6.48

7.2

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.23

6.43

2.4

—

(3017704) Immunofixation for Urine

102

2.87

6.38

1.2

1.7

—

(3027008) Opiates [Presence] in Urine

236

2.20

6.35

3.1

1.5

—

(3028300) Cannabinoids [Presence] in Urine

236

2.20

6.35

8.0

1.5

—

(3027944) Amphetamines [Presence] in Urine

233

2.18

6.13

7.6

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

253

2.13

6.12

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.98

6.12

3.6

3.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.13

6.09

1.3

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

140

2.53

6.04

1.8

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

140

2.53

6.04

1.8

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

140

2.53

6.04

1.8

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.87

5.95

1.7

2.5

—

(44806118)

179

2.32

5.88

1.6

—

(44790048)

179

2.32

5.88

1.6

—

(44790049)

179

2.32

5.88

1.6

—

(44790047)

179

2.32

5.88

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.03

5.81

2.0

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.03

5.81

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.03

5.81

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.03

5.81

2.0

1.9

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

5.53

5.81

2.2

2.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

207

1472

1.46

5.77

2.8

2.5

ug/l

10.5

7.5

0.49

188

1311

(3016750) Collection duration of Urine

103

2.75

5.70

2.0

min

475.5

493.8

0.32

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.72

5.65

1.4

1.2

ug/l

15.5

85.9

—

(3032057) Clostridioides difficile [Presence] in Stool

4.08

5.63

1.9

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

230

2.12

5.52

1.6

1.5

—

(40768443) Skin Pathology biopsy report

105

648

1.66

5.50

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.83

5.49

2.5

1.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

3.36

5.45

1.9

2.0

ug/l

85.2

62.1

0.37

(4146454)

179

2.26

5.44

3.0

2.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

259

2.04

5.41

4.8

3.6

—

(3036603) Volume of Urine

2.80

5.31

1.7

1.5

2032.5

1812.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1451

0.61

5.16

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

198

2.15

5.06

1.5

1.2

u/ml

2.8

3.4

0.15

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.58

5.05

1.0

1.1

miu/ml

1482.6

1531.2

0.07

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.65

4.99

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

193

2.15

4.96

1.6

1.2

u/ml

3.9

4.9

0.22

(3041096) Erythrocytes [Presence] in Urine by Automated

447

3675

1.29

4.94

5.1

3.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.88

4.93

3.5

4.0

—

(3011648) Oxygen content in Venous blood

137

2.36

4.84

1.5

1.9

8.0

11.2

3.49

137

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

596

6893

0.79

4.84

3.8

5.0

ug/l

1.8

3.6

1.78

520

6192

(3004616) Nuclear Ab [Presence] in Serum

176

2.18

4.80

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.02

4.78

2.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

5.02

4.78

1.0

1.1

mmol/l

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

5.02

4.78

1.0

1.1

mmol/l

—

(3000330) Specific gravity of Urine by Test strip

117

770

1.56

4.75

5.8

3.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

177

2.17

4.74

1.9

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

108

2.52

4.72

1.4

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.71

4.65

1.1

1.2

—

(40761536) Microorganisms panel - Urine sediment

170

1216

1.44

4.61

5.0

4.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.35

4.61

3.6

2.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

400

1.75

4.58

1.2

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1287

13637

0.79

4.49

5.5

4.2

mmol/l

1.4

1.3

3.52

1185

12350

(42529406) Shigella sp [Presence] in Stool by Culture

403

1.74

4.48

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

162

2.18

4.45

1.9

1.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

398

1.74

4.38

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

109

2.41

4.15

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.55

4.14

1.4

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.55

4.14

1.4

1.6

—

(3047189) Immunofixation for 24 hour Urine

2.64

4.07

1.0

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

393

0.35

4.05

1.2

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.77

4.02

1.3

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1340

14088

0.79

4.02

6.4

4.8

mmol/l

6.9

6.1

37.70

1240

12723

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

3.95

3.98

1.1

2.3

—

43.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.58

3.89

1.2

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

2.58

3.89

1.3

1.2

nmol/l

126.0

141.1

0.80

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

132

2.22

3.87

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1486

14211

1.30

3.81

45.2

15.6

mg/l

22.1

25.9

7.65

1429

11410

(3001019) Free T4 and TSH panel - Serum or Plasma

464

0.42

3.78

1.2

1.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

8.78

3.77

1.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

273

1.82

3.77

1.5

1.4

u/l

12.8

8.7

0.65

223

(3014271) Vancomycin [Susceptibility]

2.46

3.72

4.5

2.9

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.65

3.66

1.6

1.4

—

(4268621)

136

2.15

3.62

2.9

2.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

255

1.83

3.61

1.2

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

7.80

3.56

1.1

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.82

3.52

1.3

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

6.18

3.50

1.1

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

6.18

3.50

1.0

—

(3042517) Benzodiazepines panel - Urine

10.03

3.50

4.2

1.0

—

(3018572) Chloride [Moles/volume] in Blood

379

1.66

3.48

10.2

8.2

mmol/l

104.3

105.6

1.13

341

(3039000) Anion gap in Blood

379

1.66

3.48

10.2

8.2

mmol/l

12.0

11.4

0.52

341

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.43

3.47

2.4

2.2

—

(4306422)

187

1.94

3.44

1.4

1.2

—

(3019977) pH of Arterial blood

2.40

3.40

3.7

3.0

7.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

142

2.06

3.27

1.4

1.2

85.8

95.8

1.28

135

(1002224) Polysomnography panel

515

0.50

3.24

1.2

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

171

1.95

3.20

1.7

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

187

1.89

3.11

1.4

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.85

3.02

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

147

1.99

3.00

1.3

—

(3045424) Erythrocytes [Presence] in Urine

234

1.77

2.98

1.7

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

170

1.90

2.91

1.2

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

192

1.84

2.89

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.60

2.87

1.1

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

6.68

2.87

1.3

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.94

2.86

1.2

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

116

2.08

2.83

1.0

1.1

u/ml

98.2

38.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.48

2.79

2.4

2.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

8.35

2.75

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

174

1.85

2.73

4.6

4.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

125

2.01

2.71

1.8

u/field

1.5

0.04

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.61

2.70

1.3

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1476

15218

0.81

2.63

52.7

18.4

umol/l

95.3

81.7

16.97

1476

15209

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

597

5355

1.17

2.58

5.7

4.0

—

(3011412) CD3 cells [#/volume] in Blood

130

1.94

2.46

1.5

2.1

e9/l

0.6

1.1

3.52

(3034426) Prothrombin time (PT)

2.68

2.45

1.9

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

2.56

2.44

1.1

u/ml

—

16.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.36

2.39

2.5

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.36

2.39

2.5

2.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

205

1.72

2.38

2.2

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.65

2.36

13.4

10.6

mmol/l

4.1

5.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.13

2.36

1.1

—

(44806420)

2.51

2.36

2.8

2.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.27

2.34

1.3

1.2

—

(4094501)

460

0.56

2.33

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.87

2.30

2.1

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.69

2.28

8.9

7.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

549

1.42

2.25

1.1

titre

—

168.8

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.28

2.24

1.1

ratio

1.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

5.57

2.21

1.0

1.1

35.0

38.4

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

5.57

2.21

1.0

1.1

8.9

8.4

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

5.57

2.21

1.0

1.1

21.5

21.9

—

(3022621) pH of Urine by Test strip

123

951

1.32

2.18

3.5

2.9

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.03

2.16

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.03

2.16

1.2

—

(3025315) Body weight

4.30

2.15

4.8

2.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

102

769

1.35

2.15

1.3

u/ml

298.1

254.8

0.28

702

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.69

2.15

1.9

1.6

ng/l

96.3

126.3

—

(40768800) Prostate Pathology biopsy report

448

0.57

2.14

1.1

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

116

894

1.32

2.11

1.1

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.01

2.07

1.4

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.51

2.05

2.4

3.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

169

1.73

2.04

1.6

1.8

—

1400.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.12

2.02

1.3

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

2.12

2.02

7.9

13.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.34

1.96

1.1

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

430

3834

1.16

1.94

5.6

4.1

estimate

0.0

0.69

171

1248

(3004716) Salmonella sp identified in Stool by Organism specific culture

574

1.38

1.94

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.76

1.93

1.2

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.76

1.93

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.74

1.93

1.0

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.45

1.93

2.5

3.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.97

1.90

2.5

2.8

35.6

38.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.87

1.86

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.54

1.84

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.18

1.82

1.0

—

(3022689) Creatine [Moles/volume] in Urine

2.45

1.75

2.7

1.6

—

(40757373) Influenza virus identified in Isolate

2.51

1.74

1.3

1.8

—

(3026480) Teichoate Ab [Titer] in Serum

3.85

1.71

1.0

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.85

1.71

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

333

1.45

1.69

4.7

3.7

mg/l

29.3

27.7

0.08

213

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.39

1.67

1.3

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

119

1.77

1.66

1.4

1.9

u/l

13018.4

1194.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.17

1.66

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.17

1.66

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.81

1.65

1.0

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1485

15194

0.85

1.63

31.4

10.8

u/l

38.6

26.8

14.79

1466

14638

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

182

1.60

1.3

1.6

74.4

63.9

0.83

115

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.33

1.60

2.0

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

105

1311

0.79

1.59

2.2

nmol/l

12.7

13.0

0.11

1148

(3023419) Bacteria identified in Sputum by Culture

231

1.53

1.57

5.0

2.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

1.86

1.56

1.6

2.2

18.0

12.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.86

1.56

3.1

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

145

1.66

1.54

1.3

1.4

23.5

26.5

0.13

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

100

1.81

1.53

1.6

2.2

e6/l

436.0

657.5

—

(3051101) Glucose [Moles/volume] in Cord blood

2.60

1.51

18.3

6.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.60

1.51

1.3

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.86

1.50

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.16

1.50

1.1

1.2

—

(3017732) Neutrophils [#/volume] in Blood

114

923

1.25

1.48

3.4

e9/l

3.5

4.2

2.92

696

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.01

1.48

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.82

1.47

3.2

2.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.85

1.46

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.51

1.45

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

387

1.38

1.44

1.5

1.6

—

(40761511) CBC panel - Blood by Automated count

1436

14704

0.87

1.44

42.3

14.8

—

(40765096) Chromosome analysis panel by Banding

2.04

1.43

1.2

—

(3008898) HLA-B27 [Presence]

376

0.63

1.43

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.31

1.43

9.2

7.0

—

(4024509)

134

1.65

1.39

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.61

1.37

1.0

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.87

1.34

8.3

6.7

u/ml

210.2

41.7

—

(3025130) Human papilloma virus identified in Specimen

1.87

1.34

2.7

1.8

—

(3049717) Cytology report of Urine Cyto stain

711

1.27

1.32

2.7

—

(3000034) Microalbumin [Mass/volume] in Urine

145

1.59

1.29

6.0

3.2

mg/l

89.0

30.3

0.64

113

(3019832) Treponema pallidum Ab [Presence] in Serum

536

1.30

1.28

1.7

1.5

—

(3006270) Folate [Moles/volume] in Blood

122

1.65

1.27

1.4

1.2

nmol/l

272.7

365.5

0.98

103

(3044290) Cell count panel - Cerebral spinal fluid

288

1.40

1.22

1.5

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

124

1.62

1.21

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.88

1.18

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

429

1.32

1.17

1.3

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.97

1.11

1.9

—

(40761535) Cells panel - Urine sediment

153

1320

1.17

1.10

4.5

3.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1083

10452

1.09

1.08

4.1

3.8

pmol/l

14.7

14.9

2.42

989

9390

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.28

1.03

1.0

—

(3045414) Leukocytes [Presence] in Urine

636

1.24

1.02

2.3

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

174

1975

0.87

1.01

17.2

7.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.89

1.01

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.65

1.00

2.4

2.0

—

(4133840)

0.00

0.97

0.0

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

792

7565

1.09

0.97

2.9

2.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.77

0.94

1.0

1.1

—

(3024263) Appearance of Synovial fluid

1.62

0.94

1.5

1.6

—

(40758292) HTLV I+II Ab panel - Serum

2.15

0.91

1.0

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

2.07

0.89

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.00

0.87

36.7

1.9

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.94

0.84

1.2

—

183.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.74

0.82

1.3

2.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.70

0.82

1.1

1.2

iu/ml

278.7

230.0

0.14

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.88

0.82

1.0

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

1189

11589

1.08

0.81

55.9

18.8

15.4

13.8

130.63

1179

11314

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

206

1.37

0.81

3.3

2.4

mg/l

14.9

25.1

—

(3016018) Differential panel - Cerebral spinal fluid

147

1.43

0.80

1.1

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.82

0.79

1.3

115.2

109.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.82

0.79

1.0

1.3

—

(3044941) Cell count panel - Synovial fluid

260

1.31

0.78

1.3

1.4

—

(3021788) Differential panel - Synovial fluid

287

1.30

0.77

1.4

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.74

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

150

1.40

0.73

1.1

1.3

e6/l

28679.8

84851.3

0.63

104

(3014891) Appearance of Pleural fluid

2.00

0.72

1.8

1.5

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.80

0.72

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.80

0.72

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.80

0.72

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.80

0.72

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.61

0.72

1.2

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

335

1.26

0.72

1.4

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1332

13565

0.92

0.72

41.6

14.6

ml/min/173m2

73.6

77.4

6.11

1210

11254

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

117

1326

0.87

0.72

1.5

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

109

1.47

0.71

1.1

u/ml

0.2

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

684

0.83

0.70

1.5

1.7

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.71

0.70

1.0

1.8

pmol/l

13.4

14.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.55

0.69

2.7

1.2

—

66.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

339

1.24

0.66

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.73

0.64

1.2

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.73

0.64

3.2

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.73

0.64

8.2

8.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.52

0.62

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.64

0.62

1.3

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

182

1.32

0.61

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

271

1.26

0.61

1.4

iu/l

27.1

29.2

0.13

231

(3000475) Leukocytes [#/volume] in Synovial fluid

389

1.21

0.61

1.4

1.7

e6/l

17613.7

16032.0

0.08

274

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.2

—

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.57

0.60

4.6

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.57

0.60

4.6

2.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.57

0.60

2.0

ug/l

18.7

180.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.51

0.58

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

764

0.86

0.57

1.2

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.67

0.56

1.0

—

(3004451) EKG impression Narrative

1.43

0.56

1.2

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

363

0.80

0.56

1.5

1.7

—

(40768793) Breast Pathology biopsy report

263

0.76

0.56

1.3

—

(3003338) MCHC [Mass/volume]

1140

11628

0.94

0.55

58.0

20.3

g/l

330.6

332.6

8.04

1129

11540

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

228

0.74

0.54

1.3

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

100

1.40

0.52

1.4

u/ml

2.5

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.49

1.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

201

2154

0.92

0.47

1.3

1.2

u/ml

15.8

14.1

0.10

811

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.46

0.46

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.43

0.46

1.0

1.1

—

(4015189)

1.40

0.45

1.9

2.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

165

1.28

0.45

1.0

1.1

u/ml

0.9

2.0

0.63

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.61

0.43

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.56

0.42

1.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.64

0.42

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

167

1.26

0.41

1.5

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1299

12817

1.05

0.41

5.2

4.5

mu/l

2.4

2.1

1.92

1211

11573

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.52

0.41

1.4

1.1

—

0.7

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.0

—

24.8

—

(3019150) Specific gravity of Urine by Refractometry

326

3112

1.06

0.40

5.9

4.1

kg/l

1.0

0.05

454

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.43

0.39

1.0

1.1

—

14.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

133

1.28

0.38

1.1

u/ml

0.1

2.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

100

1.30

0.33

1.1

u/ml

1.0

2.4

—

(3044889) 12 lead EKG panel

1070

10547

1.04

0.31

5.0

4.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1492

15030

0.95

0.31

55.0

18.4

mmol/l

4.0

4.56

1473

14643

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.73

0.31

1.1

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.32

0.30

1.6

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

261

0.84

0.30

1.5

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

718

1.09

0.29

2.3

3.4

pmol/l

3.7

4.4

8.92

630

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.30

0.28

2.0

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

149

1.21

0.28

1.1

1.0

u/ml

1.7

5.1

1.63

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

159

1.20

0.26

1.5

1.3

nmol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.69

0.26

1.0

1.1

—

(4027681)

0.67

0.25

1.2

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

180

1.17

0.23

1.4

1.3

nmol/l

0.8

0.6

0.89

171

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.5

—

21.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

3.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.21

0.0

6.6

—

(3012898) Urea [Moles/volume] in Urine

0.00

0.21

0.0

1.3

—

153.7

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.4

—

37.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

615

0.92

0.20

1.5

1.6

—

(3023410) Appearance of Cerebral spinal fluid

145

1.17

0.20

1.4

1.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.72

0.17

22.0

11.0

nmol/l

1013.4

796.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1492

14988

0.97

0.16

54.9

18.2

mmol/l

138.0

139.7

75.14

1473

14622

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

369

1.09

0.16

1.5

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.16

0.16

1.5

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

177

1.13

0.16

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

315

1.08

0.13

1.6

1.3

e6/l

9.8

38.5

0.75

242

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

315

1.08

0.13

1.7

1.3

e6/l

163.6

779.9

0.83

251

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

201

0.89

0.13

1.2

1.1

—

13.1

—

(4034850)

479

0.94

0.13

21.4

10.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

109

0.82

0.13

1.2

1.1

titre

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1360

13539

1.02

0.12

11.1

6.1

mmol/mol

44.6

40.4

23.13

1287

12460

(3005570) Glucose [Moles/volume] in Urine

162

1.11

0.12

2.2

2.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

228

2238

1.02

0.10

1.3

iu/ml

40.8

35.3

0.28

723

(40768795) Lymph node Pathology biopsy report

135

1.11

0.09

1.4

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

134

0.89

0.08

1.1

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.03

0.08

2.3

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

146

1.10

0.08

1.1

1.0

u/ml

0.5

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

559

0.96

0.07

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

226

1.06

0.06

1.7

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

392

3955

0.99

0.06

2.0

1.7

mmol/l

1.5

1.4

2.36

355

3267

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

172

1697

1.02

0.05

1.3

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.10

0.04

1.8

1.5

—

(4010399)

112

1104

1.02

0.04

1.3

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

299

1.04

0.03

1.3

1.8

iu/l

5.0

4.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

211

1.04

0.03

3.3

4.9

umol/l

331.5

360.0

0.52

187

(3009542) Hematocrit [Volume Fraction] of Blood

1255

12569

0.99

0.02

48.5

16.8

34.7

39.7

46.03

845

8459

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

152

1.05

0.02

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

339

0.97

0.02

3.0

2.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

227

0.97

0.01

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

165

0.97

0.00

1.1

1.2

mmol/l

11.1

7.4

—

122

(3003740) Influenza virus B Ag [Presence] in Specimen

161

0.99

0.00

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

184

0.98

0.00

1.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

736

1.01

0.00

1.2

iu/ml

133.3

147.2

0.09

280

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

192

1922

1.00

0.00

5.1

4.7

30.7

32.4

1.31

158

1262

(3002523) Influenza virus A Ag [Presence] in Specimen

162

0.99

0.00

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.95

0.00

1.4

1.5

ug/l

15.4

9.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.2

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.3

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

7.5

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(44813793)

0.92

0.00

1.1

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

1.0

—

4.7

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

382.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3015183) Erythrocyte sedimentation rate

0.89

0.00

1.0

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3012565) Volume of 24 hour Urine

0.95

0.00

1.9

2.6

2156.3

1806.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.88

0.00

1.4

1.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.0

—

7.7

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

2.4

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.97

0.00

1.3

1.2

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

569.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

2.6

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.2

—

1.3

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CHIRHEP_NAS and mortality.

Females

Parameter	HR [95% CI]	p-value
CHIRHEP_NAS	8.169 [6.82, 9.79]	< 0.001
Birth year	1.0 [0.99, 1.01]	0.963

During the follow-up period (1.1.1998 — 31.12.2019), 2224 out of 3896 females with CHIRHEP_NAS died.

Males

Parameter	HR [95% CI]	p-value
CHIRHEP_NAS	9.397 [7.67, 11.51]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 3499 out of 5661 males with CHIRHEP_NAS died.

Mortality risk

Mortality risk for people of age

years, who have CHIRHEP_NAS.

N-year risk	Females	Males
1	1.008%	1.497%
5	5.56%	9.387%
10	12.789%	23.294%
15	24.546%	38.804%
20	39.066%	57.792%

Relationships between endpoints

↥

Index endpoint: CHIRHEP_NAS – Cirrhosis of liver, NAS

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cirrhosis of liver, NAS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints